Reuters logo
FDA OKs expanded indication for Edwards Lifesciences heart valve
October 19, 2012 / 7:35 PM / 5 years ago

FDA OKs expanded indication for Edwards Lifesciences heart valve

Oct 19 (Reuters) - Edwards Lifesciences Corporation said U.S. health regulators approved the use of its artificial heart valve for additional indications.

The heart valve, which is implanted using a less-invasive procedure than traditional open-heart surgery, can now be used on patients with aortic valve stenosis who are eligible for surgery but are at high risk for serious surgical complications or death.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below